Krainer M - Search Results

1

Tissue expression and serum levels of HER-2/neu in patients with breast cancer.

Krainer M, Brodowicz T, Zeillinger R, Wiltschke C, Scholten C, Seifert M, Kubista E, Zielinski CC. Krainer M, et al. Oncology. 1997 Nov-Dec;54(6):475-81. doi: 10.1159/000227606. Oncology. 1997. PMID: 9394844

2

Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.

Krainer M, Wolf H, Michl I, Wiltschke C, Budinsky A, Kaider A, Kratzik C, Eibl MM, Zielinski CC. Krainer M, et al. Cancer. 1995 Jan 15;75(2):539-44. doi: 10.1002/1097-0142(19950115)75:2<539::aid-cncr2820750217>3.0.co;2-4. Cancer. 1995. PMID: 7529130

3

Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.

Wiltschke C, Krainer M, Wagner A, Linkesch W, Zielinski CC. Wiltschke C, et al. Among authors: krainer m. Exp Hematol. 1995 May;23(5):402-6. Exp Hematol. 1995. PMID: 7536681 Clinical Trial.

4

In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.

Wiltschke C, Krainer M, Nanut M, Wagner A, Linkesch W, Zielinski CC. Wiltschke C, et al. Among authors: krainer m. J Interferon Cytokine Res. 1995 Mar;15(3):249-53. doi: 10.1089/jir.1995.15.249. J Interferon Cytokine Res. 1995. PMID: 7584671

5

[The significance of adhesion molecules in oncology].

Budinsky AC, Wiltschke C, Brodowicz T, Krainer M, Djavanmard MP, Zielinski CC. Budinsky AC, et al. Among authors: krainer m. Wien Klin Wochenschr. 1995;107(15):443-50. Wien Klin Wochenschr. 1995. PMID: 7676683 Review. German.

6

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

Wiltschke C, Krainer M, Budinsky AC, Berger A, Müller C, Zeillinger R, Speiser P, Kubista E, Eibl M, Zielinski CC. Wiltschke C, et al. Among authors: krainer m. Br J Cancer. 1995 Jun;71(6):1292-6. doi: 10.1038/bjc.1995.250. Br J Cancer. 1995. PMID: 7779726 Free PMC article.

7

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer.

Wiltschke C, Tyl E, Speiser P, Steininger A, Zeillinger R, Kury F, Czerwenka K, Kubista E, Preis P, Krainer M, et al. Wiltschke C, et al. Among authors: krainer m. Cancer. 1994 Jan 1;73(1):135-9. doi: 10.1002/1097-0142(19940101)73:1<135::aid-cncr2820730123>3.0.co;2-s. Cancer. 1994. PMID: 7903907

8

Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors.

Ludwig H, Fritz E, Leitgeb C, Krainer M, Kührer I, Sagaster P, Umek H. Ludwig H, et al. Among authors: krainer m. Ann Oncol. 1993 Feb;4(2):161-7. doi: 10.1093/oxfordjournals.annonc.a058423. Ann Oncol. 1993. PMID: 8448084 Free article.

9

Failure to confirm presence of SV40 sequences in human tumours.

Krainer M, Schenk T, Zielinski CC, Müller C. Krainer M, et al. Eur J Cancer. 1995 Oct;31A(11):1893. doi: 10.1016/0959-8049(95)00284-p. Eur J Cancer. 1995. PMID: 8541126 No abstract available.

10

Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro.

Budinsky AC, Brodowicz T, Wiltschke C, Czerwenka K, Michl I, Krainer M, Zielinski CC. Budinsky AC, et al. Among authors: krainer m. Int J Cancer. 1997 Jun 11;71(6):1086-90. doi: 10.1002/(sici)1097-0215(19970611)71:6<1086::aid-ijc27>3.0.co;2-a. Int J Cancer. 1997. PMID: 9185715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters